You are seeing Ask web results for Interleukin-6.
|
Encyclopedia: Interleukin 6
|
|
Brief and Straightforward Guide: What is Interleukin-6?
|
|
|
Interleukin-6, an inflammatory cytokine, is characterized by pleiotropy and redundancy of action. Apart from its hematologic, immune, and hepatic effects, it has many endocrine and metabolic actions. Administration of interleukin-6 results in fever, anorexia, and fatigue. Elevated levels of circulating interleukin-6...
|
|
|
My Favorite Immune Protein: Interleukin-6 Interleukin-6 is especially important in the early stages of T-cell differentiation. In this phase, it reinforces the effect of IL-2 and promotes the differentiation of CD4 cells into T-helper2 cells. (Janeway et al., 2001;
|
|
|
The IL (interleukin)-6-type cytokines IL-6, IL-11, LIF (leukaemia inhibitory factor), OSM (oncostatin M), ciliary neurotrophic factor, cardiotrophin-1 and cardiotrophin-like cytokine are an important family of mediators involved in the regulation of the acute-phase response to injury and infection.
|
|
|
Interleukin-6 (IL-6) The rationale for focussing on IL-6 as one of a key factors in etiology of AABS and neurodegeneration is based on the following evidence.
|
|
|
Interleukin 6 mediated inflammation is implicated in age-related disorders including Atherosclerosis, Peripheral Vascular Disease, Coronary Artery Disease, Osteoporosis, Type 2 Diabetes, Dementia and Alzheimer's disease and some forms of Arthritis and Cancer.
|
|
|
Interleukin-6 is made mainly by some T lymphocyte. It causes B lymphocytes to make more antibodies and also causes fever by affecting areas of the brain...
|
|
|
A key feature in the regulation of IL-6 responses has been the identification of a soluble interleukin 6 receptor (sIL-6R), which forms a ligand–receptor complex with IL-6 that is capable of stimulating a variety of cellular responses including proliferation, differentiation and activation of inflammatory processes.
|
|
|
The human interleukin IL-6 was originally cloned in 1986. In 1993, William Ershler, in his article "IL-6: A Cytokine for Gerontologists," indicated IL-6 as one of the main signaling pathways modulating the complex relationship between aging and chronic morbidity.
|
